Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Progesterone Receptors (PRs) are critical effectors of estrogen receptor (ER) signaling required for mammary gland development and reproductive proficiency. In breast and reproductive tract malignancies, PR expression is a clinical prognostic marker of ER action. While estrogens primarily regulate PR expression, other factors likely contribute to a dynamic range of receptor expression across diverse tissues. In this study, we identified estrogen-independent but progestin (R5020)-dependent regulation of ER target genes including PGR in ER+/PR+ cancer cell lines. R5020 (10 nM–10 μM range) induced dose-dependent PR mRNA and protein expression in the absence of estrogen but required both PR and ERα. Antagonists of either PR (RU486, onapristone) or ERα (ICI 182,780) attenuated R5020 induction of TFF1, CTSD, and PGR. Chromatin immunoprecipitation (ChIP) assays performed on ER+/PR+ cells demonstrated that both ERα and PR were recruited to the same ERE/Sp1 site-containing region of the PGR proximal promoter in response to high dose progestin (10 μM). Recruitment of ERα and PR to chromatin and subsequent PR mRNA induction were dependent upon rapid activation of MAPK/ERK and AKT; inhibition of these kinase pathways via U0126 or LY294002 blocked these events. Overall, we have identified a novel mechanism of ERα activation initiated by rapid PR-dependent kinase pathway activation and associated with phosphorylation of ERα Ser118 for estrogen-independent but progestin-dependent ER/PR cross talk. These studies may provide insight into mechanisms of persistent ER-target gene expression during periods of hormone (i.e. estrogen) ablation and suggest caution following prolonged treatment with aromatase or CYP17 inhibitors (i.e. contexts when progesterone levels may be abnormally elevated).

Original languageEnglish (US)
Pages (from-to)48-58
Number of pages11
JournalSteroids
Volume114
DOIs
StatePublished - 2016

Bibliographical note

Funding Information:
This study was supported by National Institutes of Health (NIH) grant R01 CA159712 (to C.A.L.), Cancer Biology Training Grant NIH T32 CA009138 (to C.H.D.), National Center for Advancing Translational Sciences of the National Institutes of Health Award UL1TR000114 (to C.H.D), and the University of Minnesota Doctoral Dissertation Fellowship (to C.H.D.). We thank Katherine A. Leehy, Ph.D. for technical support.

Keywords

  • Estrogen receptor
  • Phosphorylation
  • Progesterone receptor
  • Progestin
  • Protein kinase
  • Transcription

Fingerprint Dive into the research topics of 'Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes'. Together they form a unique fingerprint.

Cite this